Thus, Paxlovid is by far the fastest treatment for COVID-19 in the early stages.
The US Food and Drug Administration (FDA) has authorized the use of the pill in adults and children over the age of 12 who have early symptoms.
In addition, the US government plans to purchase as many doses of Paxlovid as possible, which will reach 10 million people and provide the drug to patients for free.
Patients at risk of developing severe cases are advised to start a five-day course of Paxlovid as soon as possible after diagnosis or within five days of the onset of symptoms. However, the medication is no longer prescribed when extra oxygen is needed.
Data released this week showed that Pfizer pills were almost 90% effective in hospitalization and death prevention in high-risk patients, and recent laboratory data show that the drug is effective against a new, rapidly spreading strain of the coronavirus, omicron.
Recent studies have shown that the experimental coronavirus pill developed by Pfizer reduces the risk of hospitalization or death by 89%.